1 | however | 85,572 |
2 | nonfix | 7 |
3 | heptanal | 6 |
4 | maiza | 6 |
5 | mvmax | 4 |
6 | rs6591838 | 4 |
7 | 1,4-pentadiene | 3 |
8 | 1-pentene | 3 |
9 | athlone | 3 |
10 | cas≤1 | 3 |
11 | cavanagh | 3 |
12 | dicofol | 3 |
13 | il-2srα | 3 |
14 | ly80 | 3 |
15 | mean+/-s.d. | 3 |
16 | oberdorf | 3 |
17 | pitkaranta | 3 |
18 | tmem18 | 3 |
19 | under-20s | 3 |
20 | δaicao | 3 |
21 | -0.604 | 2 |
22 | 11.50±5.92 | 2 |
23 | 4.23±4.14 | 2 |
24 | 8-epi-loganin | 2 |
25 | abamectin+levamisole+oxfendazole | 2 |
26 | additionaly | 2 |
27 | amherst | 2 |
28 | arqule | 2 |
29 | bagby | 2 |
30 | belleville | 2 |
31 | bolangir | 2 |
32 | braun-melsungen | 2 |
33 | brolin | 2 |
34 | calculation/attention | 2 |
35 | circoflex | 2 |
36 | cis-jasmone | 2 |
37 | cvrx | 2 |
38 | darkhan | 2 |
39 | dev. | 2 |
40 | di/triplegia | 2 |
41 | dimeff | 2 |
42 | eco-physiological | 2 |
43 | epo+rtpa | 2 |
44 | fmd-post | 2 |
45 | gerd- | 2 |
46 | geuder | 2 |
47 | gnrh-cr | 2 |
48 | gnrh-supl | 2 |
49 | hec-iv | 2 |
50 | hgdh | 2 |
51 | hook. | 2 |
52 | hspa13 | 2 |
53 | incstar | 2 |
54 | inserm-anrs | 2 |
55 | kivlahan | 2 |
56 | l-fmc-post | 2 |
57 | l-fmc-pre | 2 |
58 | lafkha | 2 |
59 | lezak | 2 |
60 | lps+nor | 2 |
61 | lysaker | 2 |
62 | meclastine | 2 |
63 | median-16 | 2 |
64 | medline/ovid | 2 |
65 | metribuzin | 2 |
66 | mmoptics | 2 |
67 | mtch2 | 2 |
68 | nct00297661 | 2 |
69 | neverthless | 2 |
70 | oceanside | 2 |
71 | oxytetracyclin | 2 |
72 | peg-filgrastim | 2 |
73 | pentamethylbenzene | 2 |
74 | pimps | 2 |
75 | post-epa | 2 |
76 | prolonged- | 2 |
77 | r=-0.577 | 2 |
78 | r=0.117 | 2 |
79 | r=0.666 | 2 |
80 | redent | 2 |
81 | reston | 2 |
82 | rock-1 | 2 |
83 | roelofs | 2 |
84 | rotbart | 2 |
85 | rs10273424 | 2 |
86 | rs2228261 | 2 |
87 | rs743507 | 2 |
88 | rs=-0.272 | 2 |
89 | sbm-1 | 2 |
90 | smd=1.02 | 2 |
91 | suvmax1 | 2 |
92 | t.j. | 2 |
93 | t=2.653 | 2 |
94 | tcm2000 | 2 |
95 | technicality | 2 |
96 | tigers | 2 |
97 | tlr4- | 2 |
98 | tolidaru | 2 |
99 | youmans | 2 |
100 | z=1.36 | 2 |
101 | z=1.59 | 2 |
102 | α/β=10gy | 2 |
103 | β=-0.517 | 2 |
104 | 'trastuzumab | 1 |
105 | -0.4625 | 1 |
106 | -221.05 | 1 |
107 | -45.23 | 1 |
108 | -47.22 | 1 |
109 | -62.03 | 1 |
110 | -7.1±26.1 | 1 |
111 | -fibers | 1 |
112 | 0.095-0.666 | 1 |
113 | 0.12-0.90 | 1 |
114 | 0.128-0.736 | 1 |
115 | 0.167-0.670 | 1 |
116 | 0.234-0.888 | 1 |
117 | 0.26-2.15 | 1 |
118 | 0.325-1.576 | 1 |
119 | 0.354-1.162 | 1 |
120 | 0.45-0.46 | 1 |
121 | 0.57-1.74 | 1 |
122 | 0.64-1.17 | 1 |
123 | 0.82-0.85 | 1 |
124 | 0.84-1.62 | 1 |
125 | 0.84-11.1 | 1 |
126 | 0.93-7.41 | 1 |
127 | 0.9529 | 1 |
128 | 0.96-2.49 | 1 |
129 | 0=clear | 1 |
130 | 0·458 | 1 |
131 | 1-hydroxycholecalciferol | 1 |
132 | 1.000-1.106 | 1 |
133 | 1.04-2.38 | 1 |
134 | 1.08-2.26 | 1 |
135 | 1.15-6.82 | 1 |
136 | 1.16-5.17 | 1 |
137 | 1.171-6.583 | 1 |
138 | 1.20-3.57 | 1 |
139 | 1.29-2.62 | 1 |
140 | 1.29-7.27 | 1 |
141 | 1.3-14.9 | 1 |
142 | 1.30-4.86 | 1 |
143 | 1.35-4.98 | 1 |
144 | 1.47-1.82 | 1 |
145 | 1.5-21.9 | 1 |
146 | 1.51-7.71 | 1 |
147 | 1.55-8.30 | 1 |
148 | 1.6-21.8 | 1 |
149 | 1.88-2.00 | 1 |
150 | 1.99-18.1 | 1 |
151 | 100:0.5 | 1 |
152 | 101/170 | 1 |
153 | 10×/wk | 1 |
154 | 112.4kcal | 1 |
155 | 13-o-coumaroylplumieride | 1 |
156 | 13.2±0.9 | 1 |
157 | 13.6±6.5 | 1 |
158 | 14/290 | 1 |
159 | 178.82 | 1 |
160 | 18/471 | 1 |
161 | 195:1272-1277 | 1 |
162 | 1s68g | 1 |
163 | 1·03-1·39 | 1 |
164 | 1·08-1·70 | 1 |
165 | 2.04±0.19 | 1 |
166 | 2.2+/-1.6 | 1 |
167 | 2.29±0.17 | 1 |
168 | 2.73-3.79 | 1 |
169 | 2/190 | 1 |
170 | 20.4±9.7 | 1 |
171 | 21:195s-199s | 1 |
172 | 22:142-159 | 1 |
173 | 234-42 | 1 |
174 | 25.75°s | 1 |
175 | 26,208 | 1 |
176 | 26:323-329 | 1 |
177 | 29,683 | 1 |
178 | 2=mild | 1 |
179 | 3,5,4'-tetrahydroxylstilbene-2,3-di-o-glucoside | 1 |
180 | 3.0+/-2.4 | 1 |
181 | 303:235 | 1 |
182 | 35+/-13y | 1 |
183 | 4-76 | 1 |
184 | 4-beta-d-glucanase | 1 |
185 | 4.48±0.18 | 1 |
186 | 4.74±0.18 | 1 |
187 | 5.293-37.414 | 1 |
188 | 5037 | 1 |
189 | 54.4-66.2 | 1 |
190 | 6.4nmol/kg | 1 |
191 | 6.9/18 | 1 |
192 | 66:1256-1263 | 1 |
193 | 70°c/20s | 1 |
194 | 7th-9th | 1 |
195 | 80kcal | 1 |
196 | 832m | 1 |
197 | 8ba | 1 |
198 | 9.4-69.1 | 1 |
199 | 9/212 | 1 |
200 | a=10 | 1 |
201 | ab-ac | 1 |
202 | abaxis | 1 |
203 | ac-ac | 1 |
204 | acac=acetylacetonate | 1 |
205 | acenaphthene | 1 |
206 | actimarker | 1 |
207 | ad.egr.tnf.11d | 1 |
208 | ad8 | 1 |
209 | adisseo | 1 |
210 | aesculapius | 1 |
211 | agrilabs | 1 |
212 | akkermans | 1 |
213 | ancylostomatidae | 1 |
214 | aor=0.536 | 1 |
215 | aor=0.542 | 1 |
216 | aor=0.87 | 1 |
217 | appendicitis/peritonitis | 1 |
218 | arb+diu | 1 |
219 | ares-serono | 1 |
220 | arkin | 1 |
221 | arr=0.87 | 1 |
222 | arr=1.32 | 1 |
223 | articulinx | 1 |
224 | atemicro | 1 |
225 | att=3.21 | 1 |
226 | auc00-∞ | 1 |
227 | b1=20 | 1 |
228 | b1=22 | 1 |
229 | b=2.29 | 1 |
230 | b=2.36 | 1 |
231 | b=≥65 | 1 |
232 | barren-treatment | 1 |
233 | beta=-0.144 | 1 |
234 | beta=0.144 | 1 |
235 | bifantis | 1 |
236 | bim/trav | 1 |
237 | biotek | 1 |
238 | bl+/fu- | 1 |
239 | blacks/whites/other | 1 |
240 | bloomfield | 1 |
241 | boese | 1 |
242 | bpf4 | 1 |
243 | bpydc=2,2'-bipyridine-5,5'-dicarboxylate | 1 |
244 | brandford | 1 |
245 | c+ve | 1 |
246 | c-it | 1 |
247 | c=≤64 | 1 |
248 | cassidy | 1 |
249 | cationizable | 1 |
250 | cavtratin | 1 |
251 | chepsokoyon | 1 |
252 | chi-square=1.29 | 1 |
253 | chi-square=4.083 | 1 |
254 | chi-square=5.288 | 1 |
255 | chi2=17.498 | 1 |
256 | chi2=4.22 | 1 |
257 | chi2inc=11.36 | 1 |
258 | chi=20.13 | 1 |
259 | chi²p=17.19 | 1 |
260 | chorei-to | 1 |
261 | ci=1.55 | 1 |
262 | cis-but-2-ene | 1 |
263 | clinalfa | 1 |
264 | coan | 1 |
265 | coefficient=0.238 | 1 |
266 | coote | 1 |
267 | cr+exercise | 1 |
268 | crossley | 1 |
269 | ct.cawidth | 1 |
270 | ctri/2012/05/002645 | 1 |
271 | ctrl-6 | 1 |
272 | cuemate-2-pod | 1 |
273 | cystorelin | 1 |
274 | d0401 | 1 |
275 | d=1.58 | 1 |
276 | dad=2.21 | 1 |
277 | dad=7.51 | 1 |
278 | dbp-md | 1 |
279 | denosumab/alendronate | 1 |
280 | dermapharm | 1 |
281 | dibpiv1 | 1 |
282 | dibpiv2 | 1 |
283 | dibpβ1 | 1 |
284 | dibpβ2 | 1 |
285 | diflufenican | 1 |
286 | dm/non-dm | 1 |
287 | dmf=n | 1 |
288 | dms1 | 1 |
289 | doublet/monotherapy | 1 |
290 | duderstadt | 1 |
291 | durvet | 1 |
292 | e-7010 | 1 |
293 | e-i | 1 |
294 | e1193 | 1 |
295 | e13a2+e14a2 | 1 |
296 | eba5318 | 1 |
297 | eba5319 | 1 |
298 | ecogramostim | 1 |
299 | efavirenz/zidovudine/lamivudine | 1 |
300 | enteroccocci | 1 |
301 | epma1601 | 1 |
302 | es=-0.86 | 1 |
303 | es=-1.64 | 1 |
304 | euro251 | 1 |
305 | f+a | 1 |
306 | f1,23=11.34 | 1 |
307 | f1,23=16.45 | 1 |
308 | f2,39=6.76 | 1 |
309 | f=142.432 | 1 |
310 | f=149.652 | 1 |
311 | f=18.3 | 1 |
312 | f=3.813 | 1 |
313 | f=37 | 1 |
314 | f=4.72 | 1 |
315 | f=48.6 | 1 |
316 | f=5.74 | 1 |
317 | f=6.00 | 1 |
318 | f=6.02 | 1 |
319 | f=65.951 | 1 |
320 | f=7.59 | 1 |
321 | f=84.896 | 1 |
322 | f=9.04 | 1 |
323 | fargo | 1 |
324 | farley | 1 |
325 | fischerin | 1 |
326 | g2-5 | 1 |
327 | g5=59.49 | 1 |
328 | gaudino | 1 |
329 | gc-corp | 1 |
330 | genumedi® | 1 |
331 | gipharmex | 1 |
332 | glen-anderson | 1 |
333 | gm2a | 1 |
334 | greenhalgh | 1 |
335 | guangchang | 1 |
336 | guarijio | 1 |
337 | gwaltney | 1 |
338 | gynecare/ethicon | 1 |
339 | h5=11.34 | 1 |
340 | hagoort | 1 |
341 | hanley | 1 |
342 | hec-iii | 1 |
343 | hec-v | 1 |
344 | holstein=250 | 1 |
345 | hr-0.81 | 1 |
346 | hr-1.59 | 1 |
347 | hr=1.46 | 1 |
348 | hwp1 | 1 |
349 | h₅=16.88 | 1 |
350 | icc=0.54 | 1 |
351 | ii-79.0 | 1 |
352 | im3d | 1 |
353 | instrutherm | 1 |
354 | interquim | 1 |
355 | invista | 1 |
356 | jolife | 1 |
357 | joos | 1 |
358 | junii | 1 |
359 | kappa=0.392 | 1 |
360 | kappa=0.590 | 1 |
361 | kir3.1/3.4 | 1 |
362 | kokeogh | 1 |
363 | koroyokyon | 1 |
364 | kuzminski | 1 |
365 | kyonggi-do | 1 |
366 | l-758298 | 1 |
367 | l=3,3'-bipy | 1 |
368 | laborda | 1 |
369 | lafferty | 1 |
370 | las-34475 | 1 |
371 | lateral-left | 1 |
372 | ldl7 | 1 |
373 | ln=nd | 1 |
374 | lower-carbohydrate | 1 |
375 | lsoflurane | 1 |
376 | lys377 | 1 |
377 | m2-3 | 1 |
378 | m=19.71 | 1 |
379 | m=ni | 1 |
380 | mage=15.6 | 1 |
381 | magnetites | 1 |
382 | manhica | 1 |
383 | mark1 | 1 |
384 | masnetitum | 1 |
385 | mceachin | 1 |
386 | md=4.62 | 1 |
387 | melrose | 1 |
388 | mesalamine+probiotic | 1 |
389 | metformin/glyburide | 1 |
390 | micomega | 1 |
391 | microtourism | 1 |
392 | mir-18b | 1 |
393 | mirabito | 1 |
394 | mrcruc | 1 |
395 | murakoshi | 1 |
396 | mvp/camp | 1 |
397 | mwu:103.5 | 1 |
398 | n'durance | 1 |
399 | n-cbetarotene | 1 |
400 | n=8074 | 1 |
401 | naphthopyrone | 1 |
402 | naturasone | 1 |
403 | nct01180400 | 1 |
404 | nct01539863 | 1 |
405 | nordberg | 1 |
406 | normal/training | 1 |
407 | nyscr-medicaid | 1 |
408 | oakes | 1 |
409 | olanow | 1 |
410 | olv60 | 1 |
411 | or2-year=3.03 | 1 |
412 | or3-year=7.02 | 1 |
413 | or:2.06 | 1 |
414 | or=11.24 | 1 |
415 | or=2.561 | 1 |
416 | or=2.742 | 1 |
417 | or=3.016 | 1 |
418 | or=3.87 | 1 |
419 | or=8.00 | 1 |
420 | or=9.29 | 1 |
421 | ortho-biotech | 1 |
422 | oxecta | 1 |
423 | p44 | 1 |
424 | p=.384 | 1 |
425 | p=0.664 | 1 |
426 | p=0=0.011 | 1 |
427 | partial-adherence | 1 |
428 | particullary | 1 |
429 | pat→pat | 1 |
430 | pbn-oh | 1 |
431 | peighambardoust | 1 |
432 | pelisa | 1 |
433 | pengshan | 1 |
434 | physio-control | 1 |
435 | placebo/ifnβ | 1 |
436 | placebo/ofatumumab | 1 |
437 | plug-like | 1 |
438 | pneumovax23™ | 1 |
439 | pohl-boskamp | 1 |
440 | postrandomized | 1 |
441 | powermax+38+/-7 | 1 |
442 | prietula | 1 |
443 | prockop | 1 |
444 | psa-1 | 1 |
445 | pse=38.4±11.6 | 1 |
446 | psfs=0.29 | 1 |
447 | pt0/ptis/pt1 | 1 |
448 | pubmed=54 | 1 |
449 | pyridinyl-1h-1,2,3-triazoles | 1 |
450 | r's=0.543-0.684 | 1 |
451 | r=+0.335 | 1 |
452 | r=+0.363 | 1 |
453 | r=-0.131 | 1 |
454 | r=-0.314 | 1 |
455 | r=-0.324 | 1 |
456 | r=-0.350 | 1 |
457 | r=-0.522 | 1 |
458 | r=-0.530 | 1 |
459 | r=-0.545 | 1 |
460 | r=-025 | 1 |
461 | r=0.102 | 1 |
462 | r=0.217 | 1 |
463 | r=0.288 | 1 |
464 | r=0.321 | 1 |
465 | r=0.366 | 1 |
466 | r=0.437 | 1 |
467 | r=0.581 | 1 |
468 | radicut | 1 |
469 | rapid4md | 1 |
470 | rapid4sjc | 1 |
471 | rct.pt | 1 |
472 | rd=0.17 | 1 |
473 | rd=0.20 | 1 |
474 | rdcb2 | 1 |
475 | rdcb3 | 1 |
476 | rdcho | 1 |
477 | rdpb3 | 1 |
478 | recor | 1 |
479 | rehabilitation-only | 1 |
480 | renner | 1 |
481 | rnight=-0.583 | 1 |
482 | rodger | 1 |
483 | roeko | 1 |
484 | roxicodone | 1 |
485 | rp=-.017 | 1 |
486 | rp=.315 | 1 |
487 | rp=.318 | 1 |
488 | rr0.95 | 1 |
489 | rr1.01 | 1 |
490 | rr2.1 | 1 |
491 | rr=-0.52 | 1 |
492 | rs1048261 | 1 |
493 | rs1056515 | 1 |
494 | rs10989 | 1 |
495 | rs2229562 | 1 |
496 | rs261336 | 1 |
497 | rs473224 | 1 |
498 | rs6609257 | 1 |
499 | rs8023621 | 1 |
500 | rwc/height=-0.215 | 1 |
501 | rwc=-0.210 | 1 |
502 | r₂=-0.148 | 1 |
503 | r₂=0.284 | 1 |
504 | r₃=-0.211 | 1 |
505 | r₃=0.245 | 1 |
506 | r₄=0.152 | 1 |
507 | s-3304 | 1 |
508 | s.m. | 1 |
509 | s=1043 | 1 |
510 | s=859 | 1 |
511 | saurenz | 1 |
512 | schroth | 1 |
513 | seroct | 1 |
514 | sham+hbo | 1 |
515 | shandon | 1 |
516 | sibpiv2 | 1 |
517 | simcrotech | 1 |
518 | slope=0.004 | 1 |
519 | slope=0.16 | 1 |
520 | somodi | 1 |
521 | sperber | 1 |
522 | spine-powir | 1 |
523 | st6b | 1 |
524 | stamaril® | 1 |
525 | superarray | 1 |
526 | t1/2α | 1 |
527 | t173=7.67 | 1 |
528 | t174m | 1 |
529 | t37=2.93 | 1 |
530 | t=-8.796 | 1 |
531 | t=11.47 | 1 |
532 | t=14.374 | 1 |
533 | t=2.120 | 1 |
534 | t=2.801 | 1 |
535 | t=3.230 | 1 |
536 | t=3.269 | 1 |
537 | t=3.468 | 1 |
538 | t=3.610 | 1 |
539 | t=4.317 | 1 |
540 | t=4.36 | 1 |
541 | t=4.91 | 1 |
542 | t=5.321 | 1 |
543 | t=6.762 | 1 |
544 | t=64.214 | 1 |
545 | t=7.499 | 1 |
546 | t=84.425 | 1 |
547 | tc10 | 1 |
548 | therapeuticsmd | 1 |
549 | theravalues | 1 |
550 | thuasne | 1 |
551 | tombaugh | 1 |
552 | toyo-fvg | 1 |
553 | tpa+tccd | 1 |
554 | trav/bim | 1 |
555 | trotec | 1 |
556 | trécé | 1 |
557 | tualatin | 1 |
558 | u=812 | 1 |
559 | uroarthritis | 1 |
560 | usaha | 1 |
561 | v-deltaloy | 1 |
562 | valboropro | 1 |
563 | voco-gmbh | 1 |
564 | wald=4.74 | 1 |
565 | weatherill | 1 |
566 | werkoyon | 1 |
567 | wmd/denv2=99 | 1 |
568 | wmd/denv3=138 | 1 |
569 | wmd/denv4=123 | 1 |
570 | wolmershauser | 1 |
571 | women-or | 1 |
572 | wurtele | 1 |
573 | x2=0.682 | 1 |
574 | x2=1.500 | 1 |
575 | x2=10.81 | 1 |
576 | x2=12.073 | 1 |
577 | x2=22.7 | 1 |
578 | x2=3.953 | 1 |
579 | x2=5.605 | 1 |
580 | x=3 | 1 |
581 | x=ni | 1 |
582 | yaqui | 1 |
583 | z-5.73 | 1 |
584 | z=-3.47 | 1 |
585 | z=-4.02 | 1 |
586 | z=-7.64 | 1 |
587 | z=0.99 | 1 |
588 | z=1.40 | 1 |
589 | z=1.84 | 1 |
590 | z=1.86-p=0.063 | 1 |
591 | z=1.89-p=0.058 | 1 |
592 | z=2.01 | 1 |
593 | z=2.62 | 1 |
594 | z=3.24 | 1 |
595 | z=3.37 | 1 |
596 | z=5.98 | 1 |
597 | β2=0.461 | 1 |
598 | β=-0.12 | 1 |
599 | β=-0.271 | 1 |
600 | β=-0.305 | 1 |
601 | β=0.278 | 1 |
602 | β=0.299 | 1 |
603 | δedad | 1 |
604 | δesvtte-cmr | 1 |
605 | δi0-120/δg0-120 | 1 |
606 | δmpo | 1 |
607 | δsk‡ | 1 |
608 | λabs | 1 |
609 | χ²=3.36 | 1 |
610 | χ²=5.3 | 1 |
1 | 'trastuzumab | 1 |
2 | -0.4625 | 1 |
3 | -0.604 | 2 |
4 | -221.05 | 1 |
5 | -45.23 | 1 |
6 | -47.22 | 1 |
7 | -62.03 | 1 |
8 | -7.1±26.1 | 1 |
9 | -fibers | 1 |
10 | 0.095-0.666 | 1 |
11 | 0.12-0.90 | 1 |
12 | 0.128-0.736 | 1 |
13 | 0.167-0.670 | 1 |
14 | 0.234-0.888 | 1 |
15 | 0.26-2.15 | 1 |
16 | 0.325-1.576 | 1 |
17 | 0.354-1.162 | 1 |
18 | 0.45-0.46 | 1 |
19 | 0.57-1.74 | 1 |
20 | 0.64-1.17 | 1 |
21 | 0.82-0.85 | 1 |
22 | 0.84-1.62 | 1 |
23 | 0.84-11.1 | 1 |
24 | 0.93-7.41 | 1 |
25 | 0.9529 | 1 |
26 | 0.96-2.49 | 1 |
27 | 0=clear | 1 |
28 | 0·458 | 1 |
29 | 1,4-pentadiene | 3 |
30 | 1-hydroxycholecalciferol | 1 |
31 | 1-pentene | 3 |
32 | 1.000-1.106 | 1 |
33 | 1.04-2.38 | 1 |
34 | 1.08-2.26 | 1 |
35 | 1.15-6.82 | 1 |
36 | 1.16-5.17 | 1 |
37 | 1.171-6.583 | 1 |
38 | 1.20-3.57 | 1 |
39 | 1.29-2.62 | 1 |
40 | 1.29-7.27 | 1 |
41 | 1.3-14.9 | 1 |
42 | 1.30-4.86 | 1 |
43 | 1.35-4.98 | 1 |
44 | 1.47-1.82 | 1 |
45 | 1.5-21.9 | 1 |
46 | 1.51-7.71 | 1 |
47 | 1.55-8.30 | 1 |
48 | 1.6-21.8 | 1 |
49 | 1.88-2.00 | 1 |
50 | 1.99-18.1 | 1 |
51 | 100:0.5 | 1 |
52 | 101/170 | 1 |
53 | 10×/wk | 1 |
54 | 11.50±5.92 | 2 |
55 | 112.4kcal | 1 |
56 | 13-o-coumaroylplumieride | 1 |
57 | 13.2±0.9 | 1 |
58 | 13.6±6.5 | 1 |
59 | 14/290 | 1 |
60 | 178.82 | 1 |
61 | 18/471 | 1 |
62 | 195:1272-1277 | 1 |
63 | 1s68g | 1 |
64 | 1·03-1·39 | 1 |
65 | 1·08-1·70 | 1 |
66 | 2.04±0.19 | 1 |
67 | 2.2+/-1.6 | 1 |
68 | 2.29±0.17 | 1 |
69 | 2.73-3.79 | 1 |
70 | 2/190 | 1 |
71 | 20.4±9.7 | 1 |
72 | 21:195s-199s | 1 |
73 | 22:142-159 | 1 |
74 | 234-42 | 1 |
75 | 25.75°s | 1 |
76 | 26,208 | 1 |
77 | 26:323-329 | 1 |
78 | 29,683 | 1 |
79 | 2=mild | 1 |
80 | 3,5,4'-tetrahydroxylstilbene-2,3-di-o-glucoside | 1 |
81 | 3.0+/-2.4 | 1 |
82 | 303:235 | 1 |
83 | 35+/-13y | 1 |
84 | 4-76 | 1 |
85 | 4-beta-d-glucanase | 1 |
86 | 4.23±4.14 | 2 |
87 | 4.48±0.18 | 1 |
88 | 4.74±0.18 | 1 |
89 | 5.293-37.414 | 1 |
90 | 5037 | 1 |
91 | 54.4-66.2 | 1 |
92 | 6.4nmol/kg | 1 |
93 | 6.9/18 | 1 |
94 | 66:1256-1263 | 1 |
95 | 70°c/20s | 1 |
96 | 7th-9th | 1 |
97 | 8-epi-loganin | 2 |
98 | 80kcal | 1 |
99 | 832m | 1 |
100 | 8ba | 1 |
101 | 9.4-69.1 | 1 |
102 | 9/212 | 1 |
103 | a=10 | 1 |
104 | ab-ac | 1 |
105 | abamectin+levamisole+oxfendazole | 2 |
106 | abaxis | 1 |
107 | ac-ac | 1 |
108 | acac=acetylacetonate | 1 |
109 | acenaphthene | 1 |
110 | actimarker | 1 |
111 | ad.egr.tnf.11d | 1 |
112 | ad8 | 1 |
113 | additionaly | 2 |
114 | adisseo | 1 |
115 | aesculapius | 1 |
116 | agrilabs | 1 |
117 | akkermans | 1 |
118 | amherst | 2 |
119 | ancylostomatidae | 1 |
120 | aor=0.536 | 1 |
121 | aor=0.542 | 1 |
122 | aor=0.87 | 1 |
123 | appendicitis/peritonitis | 1 |
124 | arb+diu | 1 |
125 | ares-serono | 1 |
126 | arkin | 1 |
127 | arqule | 2 |
128 | arr=0.87 | 1 |
129 | arr=1.32 | 1 |
130 | articulinx | 1 |
131 | atemicro | 1 |
132 | athlone | 3 |
133 | att=3.21 | 1 |
134 | auc00-∞ | 1 |
135 | b1=20 | 1 |
136 | b1=22 | 1 |
137 | b=2.29 | 1 |
138 | b=2.36 | 1 |
139 | b=≥65 | 1 |
140 | bagby | 2 |
141 | barren-treatment | 1 |
142 | belleville | 2 |
143 | beta=-0.144 | 1 |
144 | beta=0.144 | 1 |
145 | bifantis | 1 |
146 | bim/trav | 1 |
147 | biotek | 1 |
148 | bl+/fu- | 1 |
149 | blacks/whites/other | 1 |
150 | bloomfield | 1 |
151 | boese | 1 |
152 | bolangir | 2 |
153 | bpf4 | 1 |
154 | bpydc=2,2'-bipyridine-5,5'-dicarboxylate | 1 |
155 | brandford | 1 |
156 | braun-melsungen | 2 |
157 | brolin | 2 |
158 | c+ve | 1 |
159 | c-it | 1 |
160 | c=≤64 | 1 |
161 | calculation/attention | 2 |
162 | cassidy | 1 |
163 | cas≤1 | 3 |
164 | cationizable | 1 |
165 | cavanagh | 3 |
166 | cavtratin | 1 |
167 | chepsokoyon | 1 |
168 | chi-square=1.29 | 1 |
169 | chi-square=4.083 | 1 |
170 | chi-square=5.288 | 1 |
171 | chi2=17.498 | 1 |
172 | chi2=4.22 | 1 |
173 | chi2inc=11.36 | 1 |
174 | chi=20.13 | 1 |
175 | chi²p=17.19 | 1 |
176 | chorei-to | 1 |
177 | ci=1.55 | 1 |
178 | circoflex | 2 |
179 | cis-but-2-ene | 1 |
180 | cis-jasmone | 2 |
181 | clinalfa | 1 |
182 | coan | 1 |
183 | coefficient=0.238 | 1 |
184 | coote | 1 |
185 | cr+exercise | 1 |
186 | crossley | 1 |
187 | ct.cawidth | 1 |
188 | ctri/2012/05/002645 | 1 |
189 | ctrl-6 | 1 |
190 | cuemate-2-pod | 1 |
191 | cvrx | 2 |
192 | cystorelin | 1 |
193 | d0401 | 1 |
194 | d=1.58 | 1 |
195 | dad=2.21 | 1 |
196 | dad=7.51 | 1 |
197 | darkhan | 2 |
198 | dbp-md | 1 |
199 | denosumab/alendronate | 1 |
200 | dermapharm | 1 |
201 | dev. | 2 |
202 | di/triplegia | 2 |
203 | dibpiv1 | 1 |
204 | dibpiv2 | 1 |
205 | dibpβ1 | 1 |
206 | dibpβ2 | 1 |
207 | dicofol | 3 |
208 | diflufenican | 1 |
209 | dimeff | 2 |
210 | dm/non-dm | 1 |
211 | dmf=n | 1 |
212 | dms1 | 1 |
213 | doublet/monotherapy | 1 |
214 | duderstadt | 1 |
215 | durvet | 1 |
216 | e-7010 | 1 |
217 | e-i | 1 |
218 | e1193 | 1 |
219 | e13a2+e14a2 | 1 |
220 | eba5318 | 1 |
221 | eba5319 | 1 |
222 | eco-physiological | 2 |
223 | ecogramostim | 1 |
224 | efavirenz/zidovudine/lamivudine | 1 |
225 | enteroccocci | 1 |
226 | epma1601 | 1 |
227 | epo+rtpa | 2 |
228 | es=-0.86 | 1 |
229 | es=-1.64 | 1 |
230 | euro251 | 1 |
231 | f+a | 1 |
232 | f1,23=11.34 | 1 |
233 | f1,23=16.45 | 1 |
234 | f2,39=6.76 | 1 |
235 | f=142.432 | 1 |
236 | f=149.652 | 1 |
237 | f=18.3 | 1 |
238 | f=3.813 | 1 |
239 | f=37 | 1 |
240 | f=4.72 | 1 |
241 | f=48.6 | 1 |
242 | f=5.74 | 1 |
243 | f=6.00 | 1 |
244 | f=6.02 | 1 |
245 | f=65.951 | 1 |
246 | f=7.59 | 1 |
247 | f=84.896 | 1 |
248 | f=9.04 | 1 |
249 | fargo | 1 |
250 | farley | 1 |
251 | fischerin | 1 |
252 | fmd-post | 2 |
253 | g2-5 | 1 |
254 | g5=59.49 | 1 |
255 | gaudino | 1 |
256 | gc-corp | 1 |
257 | genumedi® | 1 |
258 | gerd- | 2 |
259 | geuder | 2 |
260 | gipharmex | 1 |
261 | glen-anderson | 1 |
262 | gm2a | 1 |
263 | gnrh-cr | 2 |
264 | gnrh-supl | 2 |
265 | greenhalgh | 1 |
266 | guangchang | 1 |
267 | guarijio | 1 |
268 | gwaltney | 1 |
269 | gynecare/ethicon | 1 |
270 | h5=11.34 | 1 |
271 | hagoort | 1 |
272 | hanley | 1 |
273 | hec-iii | 1 |
274 | hec-iv | 2 |
275 | hec-v | 1 |
276 | heptanal | 6 |
277 | hgdh | 2 |
278 | holstein=250 | 1 |
279 | hook. | 2 |
280 | however | 85,572 |
281 | hr-0.81 | 1 |
282 | hr-1.59 | 1 |
283 | hr=1.46 | 1 |
284 | hspa13 | 2 |
285 | hwp1 | 1 |
286 | h₅=16.88 | 1 |
287 | icc=0.54 | 1 |
288 | ii-79.0 | 1 |
289 | il-2srα | 3 |
290 | im3d | 1 |
291 | incstar | 2 |
292 | inserm-anrs | 2 |
293 | instrutherm | 1 |
294 | interquim | 1 |
295 | invista | 1 |
296 | jolife | 1 |
297 | joos | 1 |
298 | junii | 1 |
299 | kappa=0.392 | 1 |
300 | kappa=0.590 | 1 |
301 | kir3.1/3.4 | 1 |
302 | kivlahan | 2 |
303 | kokeogh | 1 |
304 | koroyokyon | 1 |
305 | kuzminski | 1 |
306 | kyonggi-do | 1 |
307 | l-758298 | 1 |
308 | l-fmc-post | 2 |
309 | l-fmc-pre | 2 |
310 | l=3,3'-bipy | 1 |
311 | laborda | 1 |
312 | lafferty | 1 |
313 | lafkha | 2 |
314 | las-34475 | 1 |
315 | lateral-left | 1 |
316 | ldl7 | 1 |
317 | lezak | 2 |
318 | ln=nd | 1 |
319 | lower-carbohydrate | 1 |
320 | lps+nor | 2 |
321 | lsoflurane | 1 |
322 | ly80 | 3 |
323 | lys377 | 1 |
324 | lysaker | 2 |
325 | m2-3 | 1 |
326 | m=19.71 | 1 |
327 | m=ni | 1 |
328 | mage=15.6 | 1 |
329 | magnetites | 1 |
330 | maiza | 6 |
331 | manhica | 1 |
332 | mark1 | 1 |
333 | masnetitum | 1 |
334 | mceachin | 1 |
335 | md=4.62 | 1 |
336 | mean+/-s.d. | 3 |
337 | meclastine | 2 |
338 | median-16 | 2 |
339 | medline/ovid | 2 |
340 | melrose | 1 |
341 | mesalamine+probiotic | 1 |
342 | metformin/glyburide | 1 |
343 | metribuzin | 2 |
344 | micomega | 1 |
345 | microtourism | 1 |
346 | mir-18b | 1 |
347 | mirabito | 1 |
348 | mmoptics | 2 |
349 | mrcruc | 1 |
350 | mtch2 | 2 |
351 | murakoshi | 1 |
352 | mvmax | 4 |
353 | mvp/camp | 1 |
354 | mwu:103.5 | 1 |
355 | n'durance | 1 |
356 | n-cbetarotene | 1 |
357 | n=8074 | 1 |
358 | naphthopyrone | 1 |
359 | naturasone | 1 |
360 | nct00297661 | 2 |
361 | nct01180400 | 1 |
362 | nct01539863 | 1 |
363 | neverthless | 2 |
364 | nonfix | 7 |
365 | nordberg | 1 |
366 | normal/training | 1 |
367 | nyscr-medicaid | 1 |
368 | oakes | 1 |
369 | oberdorf | 3 |
370 | oceanside | 2 |
371 | olanow | 1 |
372 | olv60 | 1 |
373 | or2-year=3.03 | 1 |
374 | or3-year=7.02 | 1 |
375 | or:2.06 | 1 |
376 | or=11.24 | 1 |
377 | or=2.561 | 1 |
378 | or=2.742 | 1 |
379 | or=3.016 | 1 |
380 | or=3.87 | 1 |
381 | or=8.00 | 1 |
382 | or=9.29 | 1 |
383 | ortho-biotech | 1 |
384 | oxecta | 1 |
385 | oxytetracyclin | 2 |
386 | p44 | 1 |
387 | p=.384 | 1 |
388 | p=0.664 | 1 |
389 | p=0=0.011 | 1 |
390 | partial-adherence | 1 |
391 | particullary | 1 |
392 | pat→pat | 1 |
393 | pbn-oh | 1 |
394 | peg-filgrastim | 2 |
395 | peighambardoust | 1 |
396 | pelisa | 1 |
397 | pengshan | 1 |
398 | pentamethylbenzene | 2 |
399 | physio-control | 1 |
400 | pimps | 2 |
401 | pitkaranta | 3 |
402 | placebo/ifnβ | 1 |
403 | placebo/ofatumumab | 1 |
404 | plug-like | 1 |
405 | pneumovax23™ | 1 |
406 | pohl-boskamp | 1 |
407 | post-epa | 2 |
408 | postrandomized | 1 |
409 | powermax+38+/-7 | 1 |
410 | prietula | 1 |
411 | prockop | 1 |
412 | prolonged- | 2 |
413 | psa-1 | 1 |
414 | pse=38.4±11.6 | 1 |
415 | psfs=0.29 | 1 |
416 | pt0/ptis/pt1 | 1 |
417 | pubmed=54 | 1 |
418 | pyridinyl-1h-1,2,3-triazoles | 1 |
419 | r's=0.543-0.684 | 1 |
420 | r=+0.335 | 1 |
421 | r=+0.363 | 1 |
422 | r=-0.131 | 1 |
423 | r=-0.314 | 1 |
424 | r=-0.324 | 1 |
425 | r=-0.350 | 1 |
426 | r=-0.522 | 1 |
427 | r=-0.530 | 1 |
428 | r=-0.545 | 1 |
429 | r=-0.577 | 2 |
430 | r=-025 | 1 |
431 | r=0.102 | 1 |
432 | r=0.117 | 2 |
433 | r=0.217 | 1 |
434 | r=0.288 | 1 |
435 | r=0.321 | 1 |
436 | r=0.366 | 1 |
437 | r=0.437 | 1 |
438 | r=0.581 | 1 |
439 | r=0.666 | 2 |
440 | radicut | 1 |
441 | rapid4md | 1 |
442 | rapid4sjc | 1 |
443 | rct.pt | 1 |
444 | rd=0.17 | 1 |
445 | rd=0.20 | 1 |
446 | rdcb2 | 1 |
447 | rdcb3 | 1 |
448 | rdcho | 1 |
449 | rdpb3 | 1 |
450 | recor | 1 |
451 | redent | 2 |
452 | rehabilitation-only | 1 |
453 | renner | 1 |
454 | reston | 2 |
455 | rnight=-0.583 | 1 |
456 | rock-1 | 2 |
457 | rodger | 1 |
458 | roeko | 1 |
459 | roelofs | 2 |
460 | rotbart | 2 |
461 | roxicodone | 1 |
462 | rp=-.017 | 1 |
463 | rp=.315 | 1 |
464 | rp=.318 | 1 |
465 | rr0.95 | 1 |
466 | rr1.01 | 1 |
467 | rr2.1 | 1 |
468 | rr=-0.52 | 1 |
469 | rs10273424 | 2 |
470 | rs1048261 | 1 |
471 | rs1056515 | 1 |
472 | rs10989 | 1 |
473 | rs2228261 | 2 |
474 | rs2229562 | 1 |
475 | rs261336 | 1 |
476 | rs473224 | 1 |
477 | rs6591838 | 4 |
478 | rs6609257 | 1 |
479 | rs743507 | 2 |
480 | rs8023621 | 1 |
481 | rs=-0.272 | 2 |
482 | rwc/height=-0.215 | 1 |
483 | rwc=-0.210 | 1 |
484 | r₂=-0.148 | 1 |
485 | r₂=0.284 | 1 |
486 | r₃=-0.211 | 1 |
487 | r₃=0.245 | 1 |
488 | r₄=0.152 | 1 |
489 | s-3304 | 1 |
490 | s.m. | 1 |
491 | s=1043 | 1 |
492 | s=859 | 1 |
493 | saurenz | 1 |
494 | sbm-1 | 2 |
495 | schroth | 1 |
496 | seroct | 1 |
497 | sham+hbo | 1 |
498 | shandon | 1 |
499 | sibpiv2 | 1 |
500 | simcrotech | 1 |
501 | slope=0.004 | 1 |
502 | slope=0.16 | 1 |
503 | smd=1.02 | 2 |
504 | somodi | 1 |
505 | sperber | 1 |
506 | spine-powir | 1 |
507 | st6b | 1 |
508 | stamaril® | 1 |
509 | superarray | 1 |
510 | suvmax1 | 2 |
511 | t.j. | 2 |
512 | t1/2α | 1 |
513 | t173=7.67 | 1 |
514 | t174m | 1 |
515 | t37=2.93 | 1 |
516 | t=-8.796 | 1 |
517 | t=11.47 | 1 |
518 | t=14.374 | 1 |
519 | t=2.120 | 1 |
520 | t=2.653 | 2 |
521 | t=2.801 | 1 |
522 | t=3.230 | 1 |
523 | t=3.269 | 1 |
524 | t=3.468 | 1 |
525 | t=3.610 | 1 |
526 | t=4.317 | 1 |
527 | t=4.36 | 1 |
528 | t=4.91 | 1 |
529 | t=5.321 | 1 |
530 | t=6.762 | 1 |
531 | t=64.214 | 1 |
532 | t=7.499 | 1 |
533 | t=84.425 | 1 |
534 | tc10 | 1 |
535 | tcm2000 | 2 |
536 | technicality | 2 |
537 | therapeuticsmd | 1 |
538 | theravalues | 1 |
539 | thuasne | 1 |
540 | tigers | 2 |
541 | tlr4- | 2 |
542 | tmem18 | 3 |
543 | tolidaru | 2 |
544 | tombaugh | 1 |
545 | toyo-fvg | 1 |
546 | tpa+tccd | 1 |
547 | trav/bim | 1 |
548 | trotec | 1 |
549 | trécé | 1 |
550 | tualatin | 1 |
551 | u=812 | 1 |
552 | under-20s | 3 |
553 | uroarthritis | 1 |
554 | usaha | 1 |
555 | v-deltaloy | 1 |
556 | valboropro | 1 |
557 | voco-gmbh | 1 |
558 | wald=4.74 | 1 |
559 | weatherill | 1 |
560 | werkoyon | 1 |
561 | wmd/denv2=99 | 1 |
562 | wmd/denv3=138 | 1 |
563 | wmd/denv4=123 | 1 |
564 | wolmershauser | 1 |
565 | women-or | 1 |
566 | wurtele | 1 |
567 | x2=0.682 | 1 |
568 | x2=1.500 | 1 |
569 | x2=10.81 | 1 |
570 | x2=12.073 | 1 |
571 | x2=22.7 | 1 |
572 | x2=3.953 | 1 |
573 | x2=5.605 | 1 |
574 | x=3 | 1 |
575 | x=ni | 1 |
576 | yaqui | 1 |
577 | youmans | 2 |
578 | z-5.73 | 1 |
579 | z=-3.47 | 1 |
580 | z=-4.02 | 1 |
581 | z=-7.64 | 1 |
582 | z=0.99 | 1 |
583 | z=1.36 | 2 |
584 | z=1.40 | 1 |
585 | z=1.59 | 2 |
586 | z=1.84 | 1 |
587 | z=1.86-p=0.063 | 1 |
588 | z=1.89-p=0.058 | 1 |
589 | z=2.01 | 1 |
590 | z=2.62 | 1 |
591 | z=3.24 | 1 |
592 | z=3.37 | 1 |
593 | z=5.98 | 1 |
594 | α/β=10gy | 2 |
595 | β2=0.461 | 1 |
596 | β=-0.12 | 1 |
597 | β=-0.271 | 1 |
598 | β=-0.305 | 1 |
599 | β=-0.517 | 2 |
600 | β=0.278 | 1 |
601 | β=0.299 | 1 |
602 | δaicao | 3 |
603 | δedad | 1 |
604 | δesvtte-cmr | 1 |
605 | δi0-120/δg0-120 | 1 |
606 | δmpo | 1 |
607 | δsk‡ | 1 |
608 | λabs | 1 |
609 | χ²=3.36 | 1 |
610 | χ²=5.3 | 1 |
1 | tlr4- | 2 |
2 | prolonged- | 2 |
3 | gerd- | 2 |
4 | bl+/fu- | 1 |
5 | mean+/-s.d. | 3 |
6 | t.j. | 2 |
7 | hook. | 2 |
8 | s.m. | 1 |
9 | dev. | 2 |
10 | ii-79.0 | 1 |
11 | 1.88-2.00 | 1 |
12 | f=6.00 | 1 |
13 | or=8.00 | 1 |
14 | tcm2000 | 2 |
15 | nct01180400 | 1 |
16 | x2=1.500 | 1 |
17 | e-7010 | 1 |
18 | rwc=-0.210 | 1 |
19 | t=3.610 | 1 |
20 | a=10 | 1 |
21 | tc10 | 1 |
22 | rd=0.20 | 1 |
23 | δi0-120/δg0-120 | 1 |
24 | t=2.120 | 1 |
25 | b1=20 | 1 |
26 | 1.55-8.30 | 1 |
27 | t=3.230 | 1 |
28 | r=-0.530 | 1 |
29 | z=1.40 | 1 |
30 | holstein=250 | 1 |
31 | r=-0.350 | 1 |
32 | olv60 | 1 |
33 | 101/170 | 1 |
34 | 0.167-0.670 | 1 |
35 | 1·08-1·70 | 1 |
36 | ly80 | 3 |
37 | 0.12-0.90 | 1 |
38 | 2/190 | 1 |
39 | 14/290 | 1 |
40 | kappa=0.590 | 1 |
41 | psa-1 | 1 |
42 | rock-1 | 2 |
43 | sbm-1 | 2 |
44 | 0.84-11.1 | 1 |
45 | rr2.1 | 1 |
46 | -7.1±26.1 | 1 |
47 | 1.99-18.1 | 1 |
48 | 9.4-69.1 | 1 |
49 | rr1.01 | 1 |
50 | z=2.01 | 1 |
51 | d0401 | 1 |
52 | epma1601 | 1 |
53 | t=2.801 | 1 |
54 | p=0=0.011 | 1 |
55 | r₃=-0.211 | 1 |
56 | dad=2.21 | 1 |
57 | att=3.21 | 1 |
58 | r=0.321 | 1 |
59 | t=5.321 | 1 |
60 | rs8023621 | 1 |
61 | r=-0.131 | 1 |
62 | 0.93-7.41 | 1 |
63 | dad=7.51 | 1 |
64 | euro251 | 1 |
65 | f=65.951 | 1 |
66 | rs2228261 | 2 |
67 | rs1048261 | 1 |
68 | β2=0.461 | 1 |
69 | or=2.561 | 1 |
70 | nct00297661 | 2 |
71 | 1.51-7.71 | 1 |
72 | m=19.71 | 1 |
73 | β=-0.271 | 1 |
74 | 18/471 | 1 |
75 | hr-0.81 | 1 |
76 | x2=10.81 | 1 |
77 | r=0.581 | 1 |
78 | t=4.91 | 1 |
79 | mark1 | 1 |
80 | hwp1 | 1 |
81 | dms1 | 1 |
82 | pt0/ptis/pt1 | 1 |
83 | dibpiv1 | 1 |
84 | suvmax1 | 2 |
85 | cas≤1 | 3 |
86 | dibpβ1 | 1 |
87 | 54.4-66.2 | 1 |
88 | smd=1.02 | 2 |
89 | z=-4.02 | 1 |
90 | f=6.02 | 1 |
91 | or3-year=7.02 | 1 |
92 | r=0.102 | 1 |
93 | β=-0.12 | 1 |
94 | 9/212 | 1 |
95 | u=812 | 1 |
96 | chi2=4.22 | 1 |
97 | -47.22 | 1 |
98 | r=-0.522 | 1 |
99 | b1=22 | 1 |
100 | arr=1.32 | 1 |
101 | f=142.432 | 1 |
102 | 234-42 | 1 |
103 | aor=0.542 | 1 |
104 | or=2.742 | 1 |
105 | rr=-0.52 | 1 |
106 | r₄=0.152 | 1 |
107 | f=149.652 | 1 |
108 | 0.84-1.62 | 1 |
109 | 1.29-2.62 | 1 |
110 | z=2.62 | 1 |
111 | md=4.62 | 1 |
112 | 0.354-1.162 | 1 |
113 | rs2229562 | 1 |
114 | t=6.762 | 1 |
115 | f=4.72 | 1 |
116 | rs=-0.272 | 2 |
117 | 1.47-1.82 | 1 |
118 | 1.15-6.82 | 1 |
119 | 178.82 | 1 |
120 | x2=0.682 | 1 |
121 | 11.50±5.92 | 2 |
122 | kappa=0.392 | 1 |
123 | e13a2+e14a2 | 1 |
124 | rdcb2 | 1 |
125 | mtch2 | 2 |
126 | dibpiv2 | 1 |
127 | sibpiv2 | 1 |
128 | dibpβ2 | 1 |
129 | m2-3 | 1 |
130 | χ²=5.3 | 1 |
131 | f=18.3 | 1 |
132 | -62.03 | 1 |
133 | or2-year=3.03 | 1 |
134 | chi=20.13 | 1 |
135 | f=3.813 | 1 |
136 | hspa13 | 2 |
137 | -45.23 | 1 |
138 | wmd/denv4=123 | 1 |
139 | s=1043 | 1 |
140 | t=2.653 | 2 |
141 | x2=3.953 | 1 |
142 | z=1.86-p=0.063 | 1 |
143 | 66:1256-1263 | 1 |
144 | r=+0.363 | 1 |
145 | nct01539863 | 1 |
146 | z-5.73 | 1 |
147 | x2=12.073 | 1 |
148 | chi-square=4.083 | 1 |
149 | rnight=-0.583 | 1 |
150 | 1.171-6.583 | 1 |
151 | 29,683 | 1 |
152 | t37=2.93 | 1 |
153 | e1193 | 1 |
154 | x=3 | 1 |
155 | rdcb3 | 1 |
156 | rdpb3 | 1 |
157 | 3.0+/-2.4 | 1 |
158 | kir3.1/3.4 | 1 |
159 | f=9.04 | 1 |
160 | slope=0.004 | 1 |
161 | s-3304 | 1 |
162 | -0.604 | 2 |
163 | 4.23±4.14 | 2 |
164 | t=64.214 | 1 |
165 | r=-0.314 | 1 |
166 | 5.293-37.414 | 1 |
167 | or=11.24 | 1 |
168 | z=3.24 | 1 |
169 | rs473224 | 1 |
170 | r=-0.324 | 1 |
171 | rs10273424 | 2 |
172 | f1,23=11.34 | 1 |
173 | h5=11.34 | 1 |
174 | beta=-0.144 | 1 |
175 | beta=0.144 | 1 |
176 | p44 | 1 |
177 | icc=0.54 | 1 |
178 | pubmed=54 | 1 |
179 | es=-1.64 | 1 |
180 | z=-7.64 | 1 |
181 | p=0.664 | 1 |
182 | c=≤64 | 1 |
183 | 0.57-1.74 | 1 |
184 | wald=4.74 | 1 |
185 | f=5.74 | 1 |
186 | n=8074 | 1 |
187 | t=14.374 | 1 |
188 | z=1.84 | 1 |
189 | r₂=0.284 | 1 |
190 | p=.384 | 1 |
191 | r's=0.543-0.684 | 1 |
192 | bpf4 | 1 |
193 | g2-5 | 1 |
194 | 100:0.5 | 1 |
195 | mwu:103.5 | 1 |
196 | 13.6±6.5 | 1 |
197 | -221.05 | 1 |
198 | β=-0.305 | 1 |
199 | x2=5.605 | 1 |
200 | 0.26-2.15 | 1 |
201 | rwc/height=-0.215 | 1 |
202 | rp=.315 | 1 |
203 | rs1056515 | 1 |
204 | r=-025 | 1 |
205 | t=84.425 | 1 |
206 | -0.4625 | 1 |
207 | 303:235 | 1 |
208 | r=+0.335 | 1 |
209 | f1,23=16.45 | 1 |
210 | r₃=0.245 | 1 |
211 | r=-0.545 | 1 |
212 | ctri/2012/05/002645 | 1 |
213 | ci=1.55 | 1 |
214 | b=≥65 | 1 |
215 | las-34475 | 1 |
216 | 0.82-0.85 | 1 |
217 | rr0.95 | 1 |
218 | ctrl-6 | 1 |
219 | 2.2+/-1.6 | 1 |
220 | pse=38.4±11.6 | 1 |
221 | mage=15.6 | 1 |
222 | f=48.6 | 1 |
223 | or:2.06 | 1 |
224 | 1.000-1.106 | 1 |
225 | median-16 | 2 |
226 | slope=0.16 | 1 |
227 | or=3.016 | 1 |
228 | 1.08-2.26 | 1 |
229 | chi2inc=11.36 | 1 |
230 | z=1.36 | 2 |
231 | b=2.36 | 1 |
232 | χ²=3.36 | 1 |
233 | t=4.36 | 1 |
234 | rs261336 | 1 |
235 | aor=0.536 | 1 |
236 | 0.128-0.736 | 1 |
237 | 0.45-0.46 | 1 |
238 | hr=1.46 | 1 |
239 | r=0.366 | 1 |
240 | 0.095-0.666 | 1 |
241 | r=0.666 | 2 |
242 | 4-76 | 1 |
243 | f2,39=6.76 | 1 |
244 | 0.325-1.576 | 1 |
245 | es=-0.86 | 1 |
246 | 1.30-4.86 | 1 |
247 | t=-8.796 | 1 |
248 | f=84.896 | 1 |
249 | powermax+38+/-7 | 1 |
250 | x2=22.7 | 1 |
251 | 20.4±9.7 | 1 |
252 | rs743507 | 2 |
253 | rd=0.17 | 1 |
254 | 2.29±0.17 | 1 |
255 | 0.64-1.17 | 1 |
256 | 1.16-5.17 | 1 |
257 | rp=-.017 | 1 |
258 | r=0.117 | 2 |
259 | r=0.217 | 1 |
260 | t=4.317 | 1 |
261 | β=-0.517 | 2 |
262 | 1.29-7.27 | 1 |
263 | z=3.37 | 1 |
264 | 5037 | 1 |
265 | r=0.437 | 1 |
266 | f=37 | 1 |
267 | t=11.47 | 1 |
268 | z=-3.47 | 1 |
269 | 1.20-3.57 | 1 |
270 | rs6609257 | 1 |
271 | t173=7.67 | 1 |
272 | 195:1272-1277 | 1 |
273 | lys377 | 1 |
274 | r=-0.577 | 2 |
275 | aor=0.87 | 1 |
276 | arr=0.87 | 1 |
277 | or=3.87 | 1 |
278 | ldl7 | 1 |
279 | 1.6-21.8 | 1 |
280 | 26,208 | 1 |
281 | 4.74±0.18 | 1 |
282 | 4.48±0.18 | 1 |
283 | 6.9/18 | 1 |
284 | rp=.318 | 1 |
285 | eba5318 | 1 |
286 | tmem18 | 3 |
287 | 1.04-2.38 | 1 |
288 | wmd/denv3=138 | 1 |
289 | coefficient=0.238 | 1 |
290 | rs6591838 | 4 |
291 | r₂=-0.148 | 1 |
292 | d=1.58 | 1 |
293 | z=1.89-p=0.058 | 1 |
294 | 0·458 | 1 |
295 | t=3.468 | 1 |
296 | β=0.278 | 1 |
297 | h₅=16.88 | 1 |
298 | r=0.288 | 1 |
299 | chi-square=5.288 | 1 |
300 | 0.234-0.888 | 1 |
301 | 1.35-4.98 | 1 |
302 | z=5.98 | 1 |
303 | l-758298 | 1 |
304 | chi2=17.498 | 1 |
305 | ad8 | 1 |
306 | 13.2±0.9 | 1 |
307 | 1.5-21.9 | 1 |
308 | 1.3-14.9 | 1 |
309 | 2.04±0.19 | 1 |
310 | chi²p=17.19 | 1 |
311 | eba5319 | 1 |
312 | psfs=0.29 | 1 |
313 | chi-square=1.29 | 1 |
314 | b=2.29 | 1 |
315 | or=9.29 | 1 |
316 | 26:323-329 | 1 |
317 | 0.9529 | 1 |
318 | 1·03-1·39 | 1 |
319 | 0.96-2.49 | 1 |
320 | g5=59.49 | 1 |
321 | hr-1.59 | 1 |
322 | z=1.59 | 2 |
323 | f=7.59 | 1 |
324 | 22:142-159 | 1 |
325 | s=859 | 1 |
326 | t=3.269 | 1 |
327 | 2.73-3.79 | 1 |
328 | rs10989 | 1 |
329 | z=0.99 | 1 |
330 | β=0.299 | 1 |
331 | t=7.499 | 1 |
332 | wmd/denv2=99 | 1 |
333 | f+a | 1 |
334 | gm2a | 1 |
335 | 8ba | 1 |
336 | manhica | 1 |
337 | laborda | 1 |
338 | clinalfa | 1 |
339 | micomega | 1 |
340 | usaha | 1 |
341 | lafkha | 2 |
342 | di/triplegia | 2 |
343 | prietula | 1 |
344 | post-epa | 2 |
345 | epo+rtpa | 2 |
346 | pelisa | 1 |
347 | oxecta | 1 |
348 | pitkaranta | 3 |
349 | invista | 1 |
350 | maiza | 6 |
351 | st6b | 1 |
352 | mir-18b | 1 |
353 | placebo/ofatumumab | 1 |
354 | 'trastuzumab | 1 |
355 | ab-ac | 1 |
356 | ac-ac | 1 |
357 | trotec | 1 |
358 | mesalamine+probiotic | 1 |
359 | rapid4sjc | 1 |
360 | mrcruc | 1 |
361 | ad.egr.tnf.11d | 1 |
362 | im3d | 1 |
363 | δedad | 1 |
364 | tpa+tccd | 1 |
365 | postrandomized | 1 |
366 | nyscr-medicaid | 1 |
367 | medline/ovid | 2 |
368 | bloomfield | 1 |
369 | 2=mild | 1 |
370 | dbp-md | 1 |
371 | rapid4md | 1 |
372 | therapeuticsmd | 1 |
373 | ln=nd | 1 |
374 | cuemate-2-pod | 1 |
375 | brandford | 1 |
376 | ancylostomatidae | 1 |
377 | n'durance | 1 |
378 | partial-adherence | 1 |
379 | 13-o-coumaroylplumieride | 1 |
380 | metformin/glyburide | 1 |
381 | oceanside | 2 |
382 | 3,5,4'-tetrahydroxylstilbene-2,3-di-o-glucoside | 1 |
383 | jolife | 1 |
384 | plug-like | 1 |
385 | cationizable | 1 |
386 | wurtele | 1 |
387 | belleville | 2 |
388 | abamectin+levamisole+oxfendazole | 2 |
389 | arqule | 2 |
390 | lsoflurane | 1 |
391 | cis-but-2-ene | 1 |
392 | acenaphthene | 1 |
393 | 1,4-pentadiene | 3 |
394 | 1-pentene | 3 |
395 | n-cbetarotene | 1 |
396 | pentamethylbenzene | 2 |
397 | efavirenz/zidovudine/lamivudine | 1 |
398 | meclastine | 2 |
399 | roxicodone | 1 |
400 | athlone | 3 |
401 | cis-jasmone | 2 |
402 | naphthopyrone | 1 |
403 | naturasone | 1 |
404 | thuasne | 1 |
405 | l-fmc-pre | 2 |
406 | 4-beta-d-glucanase | 1 |
407 | boese | 1 |
408 | cr+exercise | 1 |
409 | melrose | 1 |
410 | bpydc=2,2'-bipyridine-5,5'-dicarboxylate | 1 |
411 | denosumab/alendronate | 1 |
412 | acac=acetylacetonate | 1 |
413 | lower-carbohydrate | 1 |
414 | coote | 1 |
415 | c+ve | 1 |
416 | dimeff | 2 |
417 | oberdorf | 3 |
418 | 1s68g | 1 |
419 | 6.4nmol/kg | 1 |
420 | guangchang | 1 |
421 | normal/training | 1 |
422 | nordberg | 1 |
423 | toyo-fvg | 1 |
424 | voco-gmbh | 1 |
425 | ortho-biotech | 1 |
426 | simcrotech | 1 |
427 | hgdh | 2 |
428 | cavanagh | 3 |
429 | greenhalgh | 1 |
430 | kokeogh | 1 |
431 | tombaugh | 1 |
432 | pbn-oh | 1 |
433 | 7th-9th | 1 |
434 | ct.cawidth | 1 |
435 | schroth | 1 |
436 | e-i | 1 |
437 | enteroccocci | 1 |
438 | somodi | 1 |
439 | murakoshi | 1 |
440 | hec-iii | 1 |
441 | junii | 1 |
442 | kuzminski | 1 |
443 | m=ni | 1 |
444 | x=ni | 1 |
445 | yaqui | 1 |
446 | lezak | 2 |
447 | biotek | 1 |
448 | 10×/wk | 1 |
449 | eco-physiological | 2 |
450 | 80kcal | 1 |
451 | 112.4kcal | 1 |
452 | heptanal | 6 |
453 | weatherill | 1 |
454 | dicofol | 3 |
455 | 1-hydroxycholecalciferol | 1 |
456 | physio-control | 1 |
457 | gnrh-supl | 2 |
458 | 832m | 1 |
459 | t174m | 1 |
460 | dm/non-dm | 1 |
461 | trav/bim | 1 |
462 | peg-filgrastim | 2 |
463 | ecogramostim | 1 |
464 | interquim | 1 |
465 | dermapharm | 1 |
466 | instrutherm | 1 |
467 | microtourism | 1 |
468 | masnetitum | 1 |
469 | dmf=n | 1 |
470 | diflufenican | 1 |
471 | kivlahan | 2 |
472 | darkhan | 2 |
473 | pengshan | 1 |
474 | coan | 1 |
475 | braun-melsungen | 2 |
476 | mceachin | 1 |
477 | arkin | 1 |
478 | oxytetracyclin | 2 |
479 | cystorelin | 1 |
480 | brolin | 2 |
481 | 8-epi-loganin | 2 |
482 | fischerin | 1 |
483 | tualatin | 1 |
484 | cavtratin | 1 |
485 | metribuzin | 2 |
486 | gynecare/ethicon | 1 |
487 | shandon | 1 |
488 | calculation/attention | 2 |
489 | glen-anderson | 1 |
490 | reston | 2 |
491 | koroyokyon | 1 |
492 | chepsokoyon | 1 |
493 | werkoyon | 1 |
494 | δaicao | 3 |
495 | sham+hbo | 1 |
496 | kyonggi-do | 1 |
497 | adisseo | 1 |
498 | fargo | 1 |
499 | rdcho | 1 |
500 | guarijio | 1 |
501 | roeko | 1 |
502 | gaudino | 1 |
503 | ares-serono | 1 |
504 | δmpo | 1 |
505 | atemicro | 1 |
506 | valboropro | 1 |
507 | chorei-to | 1 |
508 | mirabito | 1 |
509 | mvp/camp | 1 |
510 | pohl-boskamp | 1 |
511 | prockop | 1 |
512 | gc-corp | 1 |
513 | 0=clear | 1 |
514 | incstar | 2 |
515 | gnrh-cr | 2 |
516 | sperber | 1 |
517 | geuder | 2 |
518 | rodger | 1 |
519 | blacks/whites/other | 1 |
520 | lysaker | 2 |
521 | actimarker | 1 |
522 | renner | 1 |
523 | wolmershauser | 1 |
524 | however | 85,572 |
525 | bolangir | 2 |
526 | spine-powir | 1 |
527 | δesvtte-cmr | 1 |
528 | women-or | 1 |
529 | recor | 1 |
530 | lps+nor | 2 |
531 | under-20s | 3 |
532 | 70°c/20s | 1 |
533 | 21:195s-199s | 1 |
534 | agrilabs | 1 |
535 | λabs | 1 |
536 | mmoptics | 2 |
537 | oakes | 1 |
538 | pyridinyl-1h-1,2,3-triazoles | 1 |
539 | magnetites | 1 |
540 | theravalues | 1 |
541 | roelofs | 2 |
542 | appendicitis/peritonitis | 1 |
543 | uroarthritis | 1 |
544 | bifantis | 1 |
545 | abaxis | 1 |
546 | akkermans | 1 |
547 | youmans | 2 |
548 | joos | 1 |
549 | pimps | 2 |
550 | -fibers | 1 |
551 | tigers | 2 |
552 | inserm-anrs | 2 |
553 | neverthless | 2 |
554 | aesculapius | 1 |
555 | 25.75°s | 1 |
556 | pat→pat | 1 |
557 | seroct | 1 |
558 | duderstadt | 1 |
559 | durvet | 1 |
560 | lateral-left | 1 |
561 | c-it | 1 |
562 | redent | 2 |
563 | barren-treatment | 1 |
564 | rct.pt | 1 |
565 | rotbart | 2 |
566 | hagoort | 1 |
567 | l-fmc-post | 2 |
568 | fmd-post | 2 |
569 | amherst | 2 |
570 | peighambardoust | 1 |
571 | radicut | 1 |
572 | arb+diu | 1 |
573 | tolidaru | 2 |
574 | hec-v | 1 |
575 | bim/trav | 1 |
576 | hec-iv | 2 |
577 | olanow | 1 |
578 | mvmax | 4 |
579 | circoflex | 2 |
580 | gipharmex | 1 |
581 | nonfix | 7 |
582 | articulinx | 1 |
583 | cvrx | 2 |
584 | 35+/-13y | 1 |
585 | superarray | 1 |
586 | bagby | 2 |
587 | cassidy | 1 |
588 | hanley | 1 |
589 | farley | 1 |
590 | crossley | 1 |
591 | gwaltney | 1 |
592 | α/β=10gy | 2 |
593 | additionaly | 2 |
594 | rehabilitation-only | 1 |
595 | v-deltaloy | 1 |
596 | doublet/monotherapy | 1 |
597 | l=3,3'-bipy | 1 |
598 | particullary | 1 |
599 | technicality | 2 |
600 | lafferty | 1 |
601 | saurenz | 1 |
602 | auc00-∞ | 1 |
603 | δsk‡ | 1 |
604 | pneumovax23™ | 1 |
605 | trécé | 1 |
606 | genumedi® | 1 |
607 | stamaril® | 1 |
608 | t1/2α | 1 |
609 | il-2srα | 3 |
610 | placebo/ifnβ | 1 |